mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Ispinesib Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |